125 related articles for article (PubMed ID: 27083299)
1. The Case | Subcutaneous abdominal calcified nodules and severe hyperphosphatemia.
Seront B; Marot L; Demoulin N; Jadoul M; Morelle J
Kidney Int; 2016 May; 89(5):1171-1172. PubMed ID: 27083299
[No Abstract] [Full Text] [Related]
2. [Calcified subcutaneous nodules in patients with chronic renal failure as a result of injections with nadroparin (Fraxiparine)].
Wanic-Kossowska M; Kozioł L; Roszkowiak B; Lacka M; Frankiewicz D; Mandel M
Pol Arch Med Wewn; 1998 May; 99(5):414-6. PubMed ID: 9816892
[TBL] [Abstract][Full Text] [Related]
3. An unusual adverse effect of nadroparin injections: Calcinosis cutis.
Nuno-Gonzalez A; Calzado-Villarreal L; Gutierrez-Pascual M; Gamo-Villegas R; Sanz-Robles H; Sanchez-Gilo A; Pinedo-Moraleda F; Lopez-Estebaranz JL
Dermatol Online J; 2011 Nov; 17(11):4. PubMed ID: 22136860
[TBL] [Abstract][Full Text] [Related]
4. Nadroparin-induced Calcinosis cutis in renal transplant recipients.
van Haren FM; Ruiter DJ; Hilbrands LB
Nephron; 2001 Mar; 87(3):279-82. PubMed ID: 11287765
[TBL] [Abstract][Full Text] [Related]
5. Hyperphosphatemic tumoural calcinosis.
Shetty S; Kapoor N; Mathai S; Paul TV
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26811414
[No Abstract] [Full Text] [Related]
6. Calcinosis of the cutis and subcutis: an unusual nonimmunologic adverse reaction to subcutaneous injections of low-molecular-weight calcium-containing heparins.
Eich D; Scharffetter-Kochanek K; Weihrauch J; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2004 Feb; 50(2):210-4. PubMed ID: 14726874
[TBL] [Abstract][Full Text] [Related]
7. Subcutis calcinosis caused by injection of calcium-containing heparin in a chronic kidney injury patient.
Fatma LB; El Ati Z; Azzouz H; Rais L; Krid M; Smaoui W; Maiz HB; Béji S; Zouaghi K; Zitouna M; Moussa FB
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1068-71. PubMed ID: 25193911
[TBL] [Abstract][Full Text] [Related]
8. [Two cases of iatrogenic cutis and subcutis calcinosis after calcium-containing heparin injection].
Bonnecarrère L; Templier I; Carron PL; Maurizi J; Salameire D; Beani JC; Blaise S
J Mal Vasc; 2009 Nov; 34(5):366-71. PubMed ID: 19782485
[TBL] [Abstract][Full Text] [Related]
9. Iatrogenic calcinosis cutis following nadroparin injection.
Giorgini S; Martinelli C; Massi D; Lumini A; Mannucci M; Giglioli L
Int J Dermatol; 2005 Oct; 44(10):855-7. PubMed ID: 16207189
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic calcinosis cutis after subcutaneous LMW-heparin administration in a hemodialysis patient.
Bulatovic A; Schlieper G; Stankovic-Popovic V; Vujic D; Floege J; Dimkovic N
Int Urol Nephrol; 2013 Aug; 45(4):1239-41. PubMed ID: 23568661
[No Abstract] [Full Text] [Related]
11. Calcinosis Cutis Caused by Subcutaneous Injection of Calcium-containing Heparin in a Patient with Systemic Lupus Erythematosus.
Hattori M; Shimizu A; Ishikawa O
Acta Derm Venereol; 2018 Jun; 98(6):614-615. PubMed ID: 29881870
[No Abstract] [Full Text] [Related]
12. [Skin necrosis induced by heparin: apropos of 2 cases].
Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
[No Abstract] [Full Text] [Related]
13. A patient with cutaneous lesions after liver transplantation.
Olde Bekkink M; Diercks GF; van den Berg AP; Tack CJ
Neth J Med; 2013 Jan; 71(1):34-7. PubMed ID: 23412823
[No Abstract] [Full Text] [Related]
14. A rare disorder: tumoral calcinosis and cirrhosis.
Allameh SF; Anari AG; Gharabaghi MA; Nakhjavani M
BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688940
[TBL] [Abstract][Full Text] [Related]
15. Severe calcinosis cutis associated with treatment of hypoparathyroidism in a dog.
Schaer M; Ginn PE; Fox LE; Leon J; Ramirez FM
J Am Anim Hosp Assoc; 2001; 37(4):364-9. PubMed ID: 11450837
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
[TBL] [Abstract][Full Text] [Related]
17. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Enoxaparin-Induced Skin Necrosis Without Thrombocytopenia.
Li J; Inwald G; Thomas M
Am J Phys Med Rehabil; 2019 May; 98(5):e51. PubMed ID: 30252691
[No Abstract] [Full Text] [Related]
19. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
20. Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.
Campanelli A; Kaya G; Masouyé I; Borradori L
Br J Dermatol; 2005 Sep; 153(3):657-60. PubMed ID: 16120161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
